L Parker Gregg - Selzman Institute for Kidney Health, Baylor College of Medicine

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 70 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Specific Gravity Improves Identification of Clinically Significant Quantitative Proteinuria from the Dipstick Urinalysis

Meredith C. Mcadams,L. Parker Gregg,Pin Xu, Song Zhang,Michael Li, Ella Carroll,Vaishnavi Kannan,DuWayne L. Willett,S. Susan Hedayati

KIDNEY360no. 6 (2024): 851-859

引用0浏览0WOS引用

Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Patients with CKD

L. Parker Gregg,Peter A. Richardson,Vijay Nambi,Laura A. Petersen,Michael E. Matheny,Salim S. Virani,Sankar D. Navaneethan

Journal of the American Society of Nephrology (2024)

引用0浏览0WOS引用

Understanding Prescribing Practices and Patient Experiences with Renin Angiotensin System Inhibitors Use in Chronic Kidney Disease: A Qualitative Study

Jennifer Arney,L. Parker Gregg,Sheena Wydermyer, Michael A. Herrera,Peter A. Richardson,Michael E. Matheny,Julia M. Akeroyd,Glenn T. Gobbel,Adriana Hung,Salim S. Virani,Sankar D. Navaneethan

CARDIORENAL MEDICINEno. 1 (2024): 34-44

引用0浏览0WOS引用

Forearm Versus Upper Arm Location of Arteriovenous Access Used at Hemodialysis Initiation: Temporal Trends and Racial Disparities

Melandrea L Worsley,Jingbo Niu, Kevin F Erickson, Neal R Barshes,Wolfgang C Winkelmayer,L Parker Gregg

American journal of kidney diseases the official journal of the National Kidney Foundation (2024)

引用0浏览0WOS引用

FACTORS ASSOCIATED WITH SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS (SGLT2I) AND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS (GLP-1 RA) PRESCRIPTIONS AMONG WOMEN VETERANS

Sehrish Ali, David Ramsey,Susan Crowley,Sankar Navaneethan,Lucile Parker Gregg

AMERICAN JOURNAL OF KIDNEY DISEASESno. 4 (2024): S68-S68

引用0浏览0引用

Cystatin C Use for CKD Detection in the Veterans Health Administration System: A Qualitative Study of Barriers and Facilitators

Julio A. Lamprea-Montealegre,Abigail Shapiro, Natalie A. B. Bontrager,Dena E. Rifkin,Simerjot K. Jassal,Lucile Parker Gregg,Sankar D. Navaneethan, Krista Navarra,Michael G. Shlipak,Michelle M. Estrella,Virginia Wang

KIDNEY MEDICINE（2024）

引用0浏览0WOS引用

Association of Antihypertensive Medications with Cardiovascular (CV) Outcomes in Patients with CKD

L Parker Gregg,Aaron R. Perkins, Hui Yang,Vijay Nambi,Susan Hedayati,Sankar D. Navaneethan,Carlos A. Alvarez

Journal of the American Society of Nephrologyno. 11S (2023): 873-873

引用0浏览0引用

The COVID-19 Pandemic: A Special Challenge for the Journal's Editors

Andreas Kronbichler,L. Parker Gregg,Joanne M. Bargman

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGYno. 12 (2023): 1945-1947

引用0浏览0WOS引用

Predictors, Disparities, and Facility-Level Variation: SGLT2 Inhibitor Prescription among US Veterans with CKD

L. Parker Gregg,David J. Ramsey,Julia M. Akeroyd, Shehrezade A. Jafry,Michael E. Matheny,Salim S. Virani,Sankar D. Navaneethan

American journal of kidney diseasesno. 1 (2023): 53-62.e1

引用4浏览0WOS引用

Validation of a predictive model for hospital-acquired acute kidney injury with emergence of SARS-CoV-2 variants

Meredith C. McAdams,Pin Xu,Michael Li,L. Parker Gregg,Sameh N. Saleh,Mauricio Ostrosky-Frid,Duwayne L. Willett,Ferdinand Velasco,Christoph U. Lehmann,S. Susan Hedayati

Journal of investigative medicine : the official publication of the American Federation for Clinical Researchno. 5 (2023): 459-464

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn